| Message: | Gonadorelin
Gonadorelin Molecular formula: C55H75N17O13.2(C2H4O2)
Gonadorelin Molecular weight: 1302.41
Gonadorelin CAS NO: 71447-49-9
Gonadorelin Active substance: Is a made synthetically LHRH receptors antagonist
Gonadorelin Appearance: White powder
Gonadorelin Usage: Mainly used for prostate cancer.
Gonadorelin is a medicine that is the same as gonadotropin-releasing hormone (GnRH) that is naturally released from the hypothalamus gland.
GnRH causes the pituitary gland to release other hormones (luteinizing hormone [LH] and follicle-stimulating hormone [FSH]). LH and FSH control development in children and fertility in adults.
Gonadorelin is used to test how well the hypothalamus and the pituitary glands are working. It is also used to cause ovulation (release of an egg from the ovary) in women who do not have regular ovulation and menstrual periods because the hypothalamus gland does not release enough GnRH.
Gonadorelin is another name for gonadotropin-releasing hormone (GnRH). It is a synthetic decapeptide prepared using solid phase peptide synthesis. GnRH is responsible for the release of follicle stimulating hormone and leutinizing hormone from the anterior pitutitary.
GnRH is available as gonadorelin hydrochloride(Factrel?)and gonadorelin diacetate tetrahydrate(Cystorelin?)for injectable use. Studies have described it being used via an infusion pump system to induce ovulation in patients with hypothalamic hypogonadism. It is also used in veterinary medicine as a treatment for cattle with cystic ovarian disease.
|
my account
